• June 16-19, 2025
  • Boston Convention & Exhibition Center

Joining Forces to Accelerate Innovation in Oncology

Loading

Joining Forces to Accelerate Innovation in Oncology

Tuesday, June 04, 2024
Breakout Session
Oncology
30ABC
Cancer poses some of the greatest challenges and areas of unmet need in medicine. Because no single therapy is likely to achieve the goal of curing and preventing cancer in all its forms, we seek to comprehensively understand the disease, its underlying biology, and its impact on patients. Inventing, discovering and developing breakthroughs in the complex field of oncology is hugely dependent on forming partnerships across the industry, including collaborations in areas such as targeted therapies, cell therapies, and ADCs. This panel will discuss how collaborations are driving innovation in oncology and what we need to focus on to further drive progress in the field.
Speakers
Mandy Jackson
Managing Editor (US Commercial News)
Scrip
Speakers
Mira Chaurushiya, PhD
Senior Partner
Westlake Village BioPartners
Gregor Fachinger, PhD
VP, Head of Oncology & Immuno-Oncology Business Development
Merck KGaA
Susan Graf, MBA
Biotech Executive, Board Member & Advisor
Visali Ramanathan
Executive Director, Head of Business Development for Oncology
Genentech

Sponsored by:

Genentech logo
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS